Pages that link to "Item:Q2510726"
Jump to navigation
Jump to search
The following pages link to (Q2510726):
Displayed 11 items.
- Development of candidates for drugs in the treatment of psychotic and cognitive disorders in dementia (Q77688) (← links)
- Development of an innovative medicine for the treatment of vaginal infections (Q77873) (← links)
- Development of an oncological drug at reduced dose using modern technologies (Q78546) (← links)
- Preclinical development of an innovative anticancer drug using the mechanism of protein reactivation p53 (Q78908) (← links)
- Development and implementation of a new generation medicine in the form of an easily applied oral solution used to combat nicotinic addiction (Q79979) (← links)
- Expansion and equipment of the Research and Development Centre of Pabianic Pharmaceutical Plants Polfa S.A. (Q80454) (← links)
- Oral, innovative drug for obesity and type 2 diabetes mellitus (Q2686383) (← links)
- Preclinical and clinical development of recombinant fusion protein in targeted anticancer therapy (Q2686384) (← links)
- Development and implementation of a modern drug complex in the therapy of hypertension (Q2686852) (← links)
- Development and implementation of a unique composition containing two substances with synergistic effect, used in the treatment of type 2 diabetes (Q4416098) (← links)
- Development and implementation of a modern hybrid SPC in the therapy of hypertension and dyslipidemia — the two most important pharmacologically modified cardiovascular risk factors (Q4417746) (← links)